-
ATNM Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
-
Institutional
- Shorts
Actinium Pharmaceuticals (ATNM)
Company Profile
Quarter (USD) | Sep 24 | Mar 24 | Dec 23 | Sep 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 78.98 mm | 78.98 mm | 78.98 mm | 78.98 mm | 78.98 mm | 78.98 mm |
Cash burn (monthly) | 1.80 mm | 1.05 mm | 4.20 mm | 3.91 mm | (no burn) | 2.17 mm |
Cash used (since last report) | 5.03 mm | 2.94 mm | 11.77 mm | 10.95 mm | n/a | 6.07 mm |
Cash remaining | 73.95 mm | 76.04 mm | 67.22 mm | 68.04 mm | n/a | 72.92 mm |
Runway (months of cash) | 41.2 | 72.4 | 16.0 | 17.4 | n/a | 33.7 |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
1 Nov 24 | June Sherie Almenoff | Stock Option Common Stock | Grant | Acquire A | No | No | 1.71 | 50,000 | 85.50 k | 50,000 |
28 Dec 23 | Sandesh Seth | Stock Option Common Stock | Grant | Acquire A | No | No | 5 | 984,367 | 4.92 mm | 984,367 |
28 Dec 23 | Shetty Ajit | Stock Option Common Stock | Grant | Acquire A | No | No | 5 | 70,311 | 351.56 k | 70,311 |
28 Dec 23 | Richard I Steinhart | Stock Option Common Stock | Grant | Acquire A | No | No | 5 | 70,311 | 351.56 k | 70,311 |